Huixiong Xu

机构：Fudan University, Zhongshan Hospital

发表论文 17 篇 · 总被引 265 次 · h-index 6

代表论文

• Integrin β4 promotes cell invasion and epithelial-mesenchymal transition through the modulation of Slug expression in hepatocellular carcinoma (2017 · Scientific Reports · 被引 95)
• MST4 kinase suppresses gastric tumorigenesis by limiting YAP activation via a non-canonical pathway (2020 · The Journal of Experimental Medicine · 被引 69)
• Role of microRNAs in hepatocellular carcinoma (2015 · Frontiers in bioscience · 被引 33)
• Combinatorial targeting of Hippo-STRIPAK and PARP elicits synthetic lethality in gastrointestinal cancers (2022 · DOAJ (DOAJ: Directory of Open Access Journals) · 被引 24)
• Novel visualized quantitative epigenetic imprinted gene biomarkers diagnose the malignancy of ten cancer types (2020 · Clinical Epigenetics · 被引 22)
• Thermal ablation and immunotherapy for hepatocellular carcinoma: Recent advances and future directions (2021 · World Journal of Gastrointestinal Oncology · 被引 15)